Inactive Instrument

Insiders MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Real-time Estimate Tradegate Other stock markets 11:46:15 31/05/2024 pm IST			5-day change	1st Jan Change
68.22 ^EUR	0.00%		0.00%	0.00%

20/05	European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	MT
17/05	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	16/01	MT
Higher Oil Prices, Interest Rate Worries Weigh on Exchange-Traded Funds, Equity Futures Premarket Wednesday	13/23/13	MT
MorphoSys Appoints Lucinda Crabtree as CFO	15/23/15	MT
Morphosys Ag Appoints Lucinda Crabtree as CFO	15/23/15	CI
Morphosys Ag Appoints Lucinda Crabtree as Member of the Management Board	15/23/15	CI
Vir Biotechnology Names New Chief Financial Officer; Shares Down	16/23/16	MT
MorphoSys CFO to Quit in March 2023	21/22/21	MT
MorphoSys AG Announces Sung Lee, Management Board Member, Decided to Leave	21/22/21	CI
German pharma company MorphoSys's finance head to step down	21/22/21	RE
MorphoSys AG Announces Executive Changes	01/22/01	CI
MorphoSys AG Announces Supervisory Board Changes	19/22/19	CI
MorphoSys Announces Departure of Roland Wandeler as Chief Operating Officer, Effective December 31, 2021	10/21/10	CI
MorphoSys Ag Announces Executive Changes	29/21/29	CI
BioNTech : Former MorphoSys Executive Joins BioNTech as CFO	18/21/18	MT
MorphoSys : Hires Sung Lee as CFO	07/21/07	MT
MorphoSys Appoints Thomas Biegi as Vice President, Head of Corporate Communications	02/20/02	CI
Jens Holstein Decides to Step Down as Member of the Morphosys AG's Management Board, Effective December 31, 2020	01/20/01	CI
MorphoSys AG Announces Resignation of Frank Morich from the Supervisory Board	28/20/28	CI
MorphoSys AG Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer, Effective May 5, 2020	22/20/22	CI
MorphoSys : Chief scientist quits at Germany's Morphosys ahead of product launch	21/19/21	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders MORPHOSYS Swiss Exchange

Equities

OXMOR

DE0006632003

Insiders

Filters